Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. Operating Income 2022–2025
Indivior Pharmaceuticals, Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Indivior Pharmaceuticals, Inc. operating income for the quarter ending March 31, 2026 was 137.0 M, a 107.58% increase year-over-year.
- Indivior Pharmaceuticals, Inc. operating income for the twelve months ending March 31, 2026 was 318.0 M.
- Indivior Pharmaceuticals, Inc. annual operating income for 2025 was 262.0 M, a 589.47% increase from 2024.
- Indivior Pharmaceuticals, Inc. annual operating income for 2024 was 38.0 M, a 125.00% decrease from 2023.
- Indivior Pharmaceuticals, Inc. annual operating income for 2023 was -152.0 M, a 87.65% increase from 2022.
- Indivior Pharmaceuticals, Inc. annual operating income for 2022 was -81.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Indivior Pharmaceuticals, Inc. Operating Income — FAQ
Indivior Pharmaceuticals, Inc. (INDV) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Indivior Pharmaceuticals, Inc.'s operating income?
Indivior Pharmaceuticals, Inc. (INDV) reported operating income of $262M for fiscal 2025.
Where can I see INDV's operating income history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s operating income by year and by quarter, including the growth rate.